Live CIRP Pipeline

Ongoing Insolvency Cases

Corporate debtors currently under CIRP — companies whose insolvency resolution is in progress, tracked from IBBI public announcements and expression-of-interest invitations. Outcomes, financials and deadlines appear on each case page as proceedings conclude.

Where the pipeline sits on the statutory clock · 3,565 dated cases
305
158
104
2,998
Under 180d — base window 180–270d — extended 270–330d — nearing outer limit Past 330d — 2,998 over the statutory outer limit
Under CIRP
3,594
cases in the live pipeline
EoI Open Now
17
actively inviting plans
Newly Admitted
160
entered CIRP in last 90 days
Avg Days in CIRP
1,451
across dated pipeline
Past 330-Day Limit
2,998
beyond the statutory outer limit
RP Profiles Linked
3,592
professionals tracked
6 of 7 cases shown · full list for members
Corporate Debtor Sector Resolution Professional In CIRP Since Statutory Position EoI Status
Vivin Drugs & Pharmaceuticals Private Limited
U24232TG2011PLC075704
 Pharmaceuticals Chillale Rajesh Nov 2024 Day 616 Closed
Global Medicines Limited
U24230GJ1994PLC021466
 Pharmaceuticals Hiten Ratilal Abhani Dec 2025 Day 227 Closed
Noida Medicare Centre Ltd.
L24239DL1988PLC031972
 Pharmaceuticals Ritu Rastogi May 2020 Day 2245 Closed
Prodo Technologies Private Limited
U24230DL2021PTC381425
 Pharmaceuticals Vijay Kumar Gupta Jun 2025 Day 385 Closed
Proto Developers and Technologies Limited
L24233UP1994PLC016444
 Pharmaceuticals Garima diggiwal Sep 2025 Day 314 Closed
S.m. Pharmaceuticals Private Limited
U24230KA2018PTC119625
 Pharmaceuticals Nethi Mallikarjuna Setty Jun 2025 Day 393 Closed
⌕ 1 more ongoing cases

The full live pipeline is for members

You're seeing 6 of 3,594 companies under CIRP — with RP, sector, statutory-clock position and exact EoI deadlines on every row. Each preview company above opens in full.

See plans →
EoI deadlines, dates & case intelligence
Exact EoI deadlines, PRA list dates, objection windows and weekly pipeline updates are part of stressed.in subscriber access — built for ARCs, PE funds and resolution professionals.
Request access →